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Objective: Clinical classifications attempt to summarize a large amount of information in a few indices. CEAP is the most
comprehensive and widely used classification of chronic venous disorders. The objective was to evaluate, in a routine
clinical setting, the information associated with each CEAP clinical class and their ascending severity and additivity.
Methods: This work was a multicenter evaluation of newly designed software dedicated to the management of venous
diseases. Forty-nine angiologists from nine European countries entered a total of 872 full records of unselected patients.
The data were analyzed to evaluate the informational value of each of the clinical classes and to test their ascending severity
and additivity, with monovariate and multivariate statistical techniques with SPSS/PC software on the database of the
872 right lower limbs.
Results: The series consisted of 700 women (80.3%) and 172 men, aged 18 to 100 years (median, 53 years). The ascending
severity of the classes was shown with the statistical association of higher severity C classes with the age of the patient, a
history of previous deep vein thrombosis, the diameter class of the most dilated varicose vein, venous symptoms, and the
presence of a corona phlebectatica. The additivity, as measured with the Cronbach  coefficient analysis, was satisfactory
in highest classes but poorer within the first three classes, and factor analysis of correspondences showed the heterogeneity
of the variables that make the classification.
Conclusion: The information summarized with the CEAP clinical classes shows a good ascending severity but a poorer
additivity. These limitations seem to be related to the heterogeneity of the information content, which suggests some
refinements of this basic tool for clinical research in the field of chronic venous disorders. (J Vasc Surg 2003;37:827-33.)
The wide spectrum of clinical venous disorders needs
classification of subgroups of patients in a standardized
fashion to allow clinical researchers to communicate about
well-defined categories of patients. After the pioneering
work of Widmer, Kamber, and Leu,1 designed for epide-
miologic surveys, and the SVS/ISCVS classification,2 im-
proved by Becker,3 the CEAP classification system was
proposed in 1995.4 This system provides a framework for a
clearly structured information about the clinical, etiologic,
anatomic, and pathophysiologic status of a lower limb with
chronic venous disease. The clinical section of this classifi-
cation is also designed to allow a severity gradation of the
disease in seven steps, from class C0 to class C6.4,5
This classification offers a comprehensive view of venous
insufficiency and has received many positive comments.6-13 It
is already widely used in clinical research publications,14-16
and improvements of the clinical part of the classification have
been suggested.17 However, thorough validation data are
scarce. We recently published a work addressing the reproduc-
ibility and showing some limitations in the interobserver re-
producibility, mostly explained by the lack of clear operational
definition of the clinical items.18 This manuscript is aimed to
assess the informative content and principally the ascending
severity and additivity of the clinical section of the CEAP
classification in a wide panel of routine clinical settings.
MATERIAL AND METHODS
A cooperative group of colleagues tested a new soft-
ware tailored for venous patients (European Phlebological
File [EPF]19) that allows an automatic rating of the CEAP
classification and scores. The colleagues were asked to
achieve a full completion of the clinical items needed for the
documentation of the C component of the CEAP and to
document the other parts as carefully as possible. Both legs
were examined and classified in every patient. Any patient
aged 18 years or older with consultation for chronic venous
disorder was eligible. No obligation was made to fulfill a
series of consecutive patients.
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The EPF software facilitates the completeness of the
records as it asks for the items lacking to produce a compre-
hensive designation in the CEAP classification. The software
provides illustrations of clinical items when requested by the
user. Recorded CEAP C items include: telangiectases and
reticular veins (C1); varicose veins (C2); edema (C3), recog-
nized when ascribed by the clinician to venous dysfunction,
with several prompts made in the EPF software to help the
investigator rule out edema of nonvenous origin (cardiac,
renal, hepatic, and lymphatic); eczema, pigmentation, and
lipodermatosclerosis (C4); white atrophy (atrophie blanche),
defined as an area of whitish and atrophic skin surrounded
by dilated capillaries and pigmentation, occurring before
ulceration (differentiated from ulcer scar from the patient’s
history),20 considered “a skin change ascribed to venous
disease” and therefore assigned to class C44; and healed
(C5) and open (C6) ulcerations.
The software also asks for recording of additional clin-
ical items or more detailed refinements. Presence of a
corona1 was specifically recorded but not taken into ac-
count directly in the calculation of the C class. However, by
definition, every patient with corona showed telangiecta-
ses/reticular veins and therefore validated the criteria for
class C1.4 Ankle stiffness, as a consequence of cutaneous
sclerosis of the ankle region, was evaluated with physical
examination and assessed in three severity grades (0, ab-
sence; 1, reducible stiffness; and 2, nonreducible/ankylosis).
It was not taken into account in the calculation of the C class.
Venous symptoms were defined as all symptoms attributable
to venous dysfunction, such as aching, pain, congestion, skin
irritation and muscle cramps, heaviness, tension, and feelings
of swelling and itching, influenced by standing-still position
and heat. Venous symptoms were recorded even in the ab-
sence of any associated physical sign of chronic venous disor-
der (class C0s). Other anamnestic information was collected,
such as a history of deep venous thrombosis. The diameter of
the most dilated vein when clinically evaluated in standing
position was also recorded21 and resulted in a limb rating of
one of four grades: 4 mm or less, between 4 and 8 mm,
between 9 and 12 mm, and more than 12 mm.
The data were analyzed to evaluate the informational
value of each of the seven clinical classes and to assess their
ascending severity as external consistency (clinical classes
versus other variables not taken into account in the classi-
fication but known to be linked with clinical severity) and
additivity (ie, every limb of a given class should include the
criteria for the lower order classes) with the Cronbach 
coefficient.22,23 Both monovariate and multivariate statis-
tical techniques were used for this purpose and performed
with SPSS/PC software (Chicago, Ill) on the database.
These included 2 tests, 2 tests with rank correlation when
appropriate, calculation of the Cronbach  reliability coef-
ficient, and factorial analysis of correspondences. This latter
multifactorial analysis summarizes a large set of variables in
a small number of extracted factors, allowing illustration of
their relationship through their association in building one
or some of the factors. These new factors are orthogonal
linear functions of the genuine variables, which means that
they are statistically independent from each other.23 The
normalized coefficient of each genuine variable in the factorial
functions and its correlation coefficient allow comparison of
their contributions to the factor. After verification of the
absence of significant differences between the left and right
lower limbs, statistical analysis was performed on the 872
right limbs to rule out overestimation of the statistical
power from the nonindependence of both limbs in a single
person.
RESULTS
Description of the patient series. Forty-nine angi-
ologists (including eight surgeons) from nine different
European countries participated in the study. The series
Table I. Main characteristics of patients’ series
Women (n  700) Men (n  172)
Age (median; range; y) 50 (38-64) 62 (48-71)
History of deep vein thrombosis 10.8% 23.0%
Weight (median; interquartile; kg) 63 (56-72) 80 (70-88)
Height (median; interquartile; m) 1.64 (1.60-1.68) 1.75 (1.70-1.80)
Body mass index (median; interquartile; kg/m2) 23.5 (20.6-27.3) 25.9 (23.3-28.1)
Table II. CEAP clinical classes: Comparison of right versus left lower limbs (2 test, not significant)
Class Description Right limbs Left limbs
C0 No visible or palpable sign of venous disease 11.0% 11.8%
C1 Telangiectases or reticular veins (subdermal, nonpalpable, diameter  4 mm) 20.9% 22.4%
C2 Varicose veins (subcutaneous, palpable, diameter  4 mm) 30.2% 27.4%
C3 Edema 19.4% 20.0%
C4 Skin changes ascribed to venous disease (pigmentation, venous eczema,
lipodermatosclerosis)
11.6% 11.6%
C5 Skin changes as defined previously with healed ulceration 1.9% 2.8%
C6 Skin changes as defined previously with active ulceration 4.8% 4.0%
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consisted of 872 patients with full clinical data recording
entered from January 1 to September 30, 1998. The series
consisted of 700 women (80.3%) and 172 men, aged 18 to
100 years (median, 53 years). One hundred fifty-two pa-
tients (17.4%) reported a history of deep vein thrombosis.
The main features of the patients sampled are summarized
in Tables I and II.
External consistency. Comparison of the seven
CEAP C classes with variables known for their relation to
the clinical severity of chronic venous diseases shows a good
external consistency of the classification. Limbs reported by
the patient as sites of previous deep vein thrombosis were
classified in significantly higher classes than limbs without
such a history (2 test, P .001; Spearman rank correlation
coefficient, r  0.33; Fig 1). Mean age progressively in-
creased from the lowest to the highest classes. This was
expected in a disease in which age is one of the main risk
factors22,23 (analysis of variance, P  .001 for both gen-
ders; correlation coefficient, r 0.44 for men and 0.41 for
women; Fig 2). A significant rank correlation was found
between classes of diameter of varicose veins as clinically
evaluated and the assigned C class (2 test, P  .001;
Spearman rank correlation coefficient, r 0.33; Table III).
The proportion of patients with venous symptoms signifi-
cantly increased with the C class (2 test, P  .001; Spear-
man rank correlation coefficient, r  0.32; Fig 3, A).
Similarly, an association was seen of corona phlebectatica1
to clinical severity classes (2 test, P .001; Spearman rank
correlation coefficient, r 0.28; Fig 3, B), which suggested
that the corona should not be considered similar to telan-
giectases and reticular veins in other locations. We also
found a significant relationship between the degree of ankle
stiffness and the clinical classes (2 test, P .001; Spearman
rank correlation coefficient, r  0.22).
Additivity. Regarding the additivity of the clinical
classes (Table IV), it is striking that none of the 42 limbs
with open ulcers (class 6) included the criteria for all five of
the lower classes. A close analysis of the discrepancies allows
the following statements. Classes 3 to 6 showed good
additivity but with the obvious built-in limitation that
Fig 1. Proportion of limbs with history of previous deep vein thrombosis (DVT) in each CEAP clinical class (2, P
.001; Spearman rank correlation coefficient, r  0.33).
Fig 2. Age by CEAP clinical class (mean and 95% CI) in men and women (analysis of variance: gender, r 0.021; age,
P  .001; correlation coefficient, r  0.44 for men and 0.41 for women).
JOURNAL OF VASCULAR SURGERY
Volume 37, Number 4 Carpentier et al 829
because a large proportion of open ulcers were the first
episode, they occurred in limbs with no ulcer scar. The
association pattern of skin changes within class C4 showed
that pigmentation and eczema were more common and less
tightly linked to ulcers than lipodermatosclerosis (Fig 4)
and white atrophy (data not shown). The presence of
telangiectases was poorly associated with the other venous
physical signs (Table IV).
The  coefficient of Cronbach analysis (Table V)
showed a poor reliability with any set of C class criteria
containing C1 and C2 (0.08 to 0.49). In contrast, a much
better score was obtained with the criteria of upper classes
(0.61 to 0.74).
Factor analysis was performed with the clinical symp-
toms and signs of venous insufficiency used in the CEAP
classification (ie, telangiectases, reticular veins, varicose
veins, edema, atrophie blanche, skin sclerosis, dermatitis,
pigmentation, healed ulceration, active ulceration, symp-
toms) and some non-CEAP items (ankle stiffness and co-
rona phlebectatica). The analysis confirms the multidimen-
sional information given by the classification because
several orthogonal (mathematically independent) factors
can be extracted from the data set, the first four of which
explain as much as 58% of the total variance. Analysis of the
correlations of the genuine clinical parameters with each of
the extracted factors allows a crude “clinical” interpretation
of these factors. The “varicose veins” factor contrasts with
the “trophic changes” and the “telangiectases” dimensions.
This analysis also suggests a relationship between symp-
toms and edema, both of which are linked to the same
fourth extracted factor (Table VI).
DISCUSSION
This study shows the feasibility of a multicenter collec-
tion of cases with the CEAP classification and a common
software that aims at improving the homogeneity of the
clinical assessment and recording procedures. The data
analyzed in this study were derived from a large number of
patients with consultation for a variety of venous disorders.
The data were collected by clinicians with different prac-
tices in different countries. Therefore, the data are not
similar to the general population nor representative of a
specific kind of patient with consultation for venous dis-
ease. However, the data are likely to provide adequate
material for a thorough detection of potential pitfalls of the
classification.
Results regarding the external consistency clearly show
that the conceptual framework of classes with ascending
severity is correct, as far as groups of patients are concerned.
An increasing degree of the mean value of each severity
index tested correlates with increasing C classes. That is
Fig 3. A, Proportion of limbs with symptoms in each CEAP
clinical class (2, P  .001; Spearman rank correlation coefficient,
r  0.32). B, Proportion of limbs with corona phlebectatica in
each CEAP clinical class (2, P .001; Spearman rank correlation
coefficient, r  0.28).
Table III. CEAP clinical classes: Association with venous maximal diameter (clinically measured in standing position)
Maximal vein diameter
CEAP clinical class
4 mm
(n  653)
Between 4 and 8 mm
(n  130)
Between 8 and 12 mm
(n  66)
12 mm
(n  23)
C0 15% 0 0 0
C1 28% 1%† 0 0
C2 24%* 60%* 33% 30%
C3 20% 18% 17%* 22%*
C4 8% 13% 36% 22%
C5 1% 4% 6% 4%
C6 4% 4% 8% 22%
2, P  .001; Spearman rank correlation coefficient, r  0.33.
*Median class.
†Large vein with no tortuosity and no reflux.
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true for risk factors (age, pregnancy), etiologic subsets
(postthrombotic syndrome), clinical indexes of severity not
taken into account in the definition of classes (symptoms,
corona phlebectatica, ankle stiffness), and pathophysiologic
abnormalities (hemodynamic data to be published sepa-
rately). This part of the results confirms the correctness of
postulations by many published studies that used such a
classification for pathophysiologic studies in which only
group comparisons were needed.
Results regarding additivity are quite satisfactory for
the three highest classes but much less so for the three
lowest. Several explanations can be given for this limitation
and may lead to possible improvements in the classification.
Although the conceptual definition of clinical findings
is quite simple, there is a lack of clear-cut operational
criteria for a nonambiguous classification of the limbs,
which is evident for edema. Edema has great clinical vari-
ability and is difficult to assess in minor cases. This also
could be said for the border line between classes 1 and 2,
and the same is true for the small group of patients with
healed or active ulcers without significant trophic changes
that do not find any place in the classification. This absence
of standardized operational criteria is probably the main
reason for the lack of interobserver reproducibility that we
recently showed for the same three first classes,18 but it
could also alter the consistency of data gathering by the
observers, thereby influencing the additivity. We believe
that improvements in that direction are mandatory.
Another part of the explanation is the composite nature
of the information taken into account in the classification:
both Cronbach  coefficient analysis and the factor analysis
of principal components show that the clinical information
on the cutaneous and the venous status cannot be accu-
rately summarized in a single scale. This is not only because
of an obvious difference in their natures but also because of
a too poor correlation in their respective severities. Indeed,
the present classification already separates the information
for symptoms and signs. A similar conceptual distinction
could be considered for venous and cutaneous abnormali-
ties. In this respect, it is doubtful that we need a clinical
venous scale because the Anatomic and Pathophysiologic
parts of the CEAP classification already provide the neces-
sary information on venous status. We think it more impor-
tant to strengthen the cutaneous dimension of the evalua-
tion of the clinical status, and a more refined appraisal of
those signs could be proposed. This could split the present
Fig 4. Venn diagram of association pattern of venous skin trophic
changes and proportion of limbs with ulcers for each association.
Surface areas of subsets are proportional to number of correspond-
ing limbs. Limbs with leg ulcers (open or healed) appear as hatched
areas.
Table IV. Additivity of “C” clinical classes
Limbs
with
perfect additivity
Additivity
with
telangiectases
Additivity
with
varicose veins
Additivity
with
edema
Additivity
with
skin changes
Additivity
with
ulcer scars
Class C0 (n  96) 96 (100%)
Class C1 (n  182) 182 (100%)
Class C2 (n  265) 165 (62.3%) 62.3%
Class C3 (n  169) 37 (21.9%) 66.9% 61.5%
Class C4 (n  101) 9 (8.9%) 70.3% 78.2% 63.4%
Class C5 (n  17) 2 (11.8%) 82.4% 82.4% 70.6% 94.1%
Class C6 (n  42) 0 52.4% 81.0% 88.1% 90.5% 42.9%
Table V. Internal reliability of “C” clinical classes: The 
Cronbach coefficient
Criteria associated
in same leg
Reliability:  Cronbach
coefficient
C1  C2 0.08
C2  C3 0.30
C3  C4 0.68
C4  C5 0.74
C5  C6 0.61
C1  C2  C3 0.20
C1  C2  C3  C4 0.38
C1  C2  C3  C4  C5 0.43
C1  C2  C3  C4  C5  C6 0.49
C2  C3  C4  C5  C6 0.59
C3  C4  C5  C6 0.63
C4  C5  C6 0.63
High reliability is obtained with upper classes. Deficiency is principally linked
with discrepancies between C2 and C3 and even more between C1 and C2.
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class 4 into two subsets, as already proposed by Coleridge-
Smith (Communication to the Third Pacific Vascular Sym-
posium, Nov 2-6, 1999, Mauna Lani, Hawaii). On the
other hand, if a clinical venous scale were to be built, we
think that diameter classes could be taken into account
(Table III).21 We would also suggest a stronger consider-
ation of the corona phlebectatica, which in most cases does
indicate a more severe venous disease than telangiectases
and reticular veins in other locations (Fig 3, B).
Obviously, it is too early to make a formal proposal for
an improved clinical classification on the basis of the data of
a single study. More data, obtained form other studies with
different designs, are needed to document the easiest way
to grade the clinical severity with better consistency and
reproducibility.
CONCLUSION
Our data support the conceptual framework of ascend-
ing severity classes, which makes the C of CEAP quite
suitable for pathophysiologic studies. Evaluation of addi-
tivity shows nice scoring for upper classes but discrepancies
in the lower ones. Factorial analysis partly explains this
limitation, showing the multidimensional structure of the
information content; it contrasts especially the “venous”
and “skin trophic changes” dimensions. The latter provides
the best additivity and could be refined through the intro-
duction of two C4 subclasses; other refinements with co-
rona phlebectatica and ankle stiffness might be tested in the
future. More accurate operational definitions of the lower
classes could be another way of improving the informa-
tional significance of the classification to optimize a tool
that is of crucial importance for progress toward a better
understanding of venous diseases.
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